Yüklüyor......
Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development
Poly (ADP-ribose) polymerase (PARP) inhibitors have shown promising activity in epithelial ovarian cancers, especially relapsed platinum-sensitive high-grade serous disease. Consistent with preclinical studies, ovarian cancers and a number of other solid tumor types occurring in patients with delete...
Kaydedildi:
| Yayımlandı: | J Clin Oncol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Clinical Oncology
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4517072/ https://ncbi.nlm.nih.gov/pubmed/25779564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.58.8848 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|